ID   WNK1_HUMAN              Reviewed;        2634 AA.
AC   Q9H4A3-5;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   12-OCT-2022, entry version 215.
DE   RecName: Full=Isoform 4 of Serine/threonine-protein kinase WNK1 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:10660600};
DE   AltName: Full=Erythrocyte 65 kDa protein;
DE            Short=p65;
DE   AltName: Full=Kinase deficient protein;
DE   AltName: Full=Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};
DE   AltName: Full=Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};
DE            Short=hWNK1;
GN   Name=WNK1 {ECO:0000312|HGNC:HGNC:14540};
GN   Synonyms=HSN2 {ECO:0000303|PubMed:15060842}, KDP, KIAA0344
GN   {ECO:0000312|EMBL:BAA20802.2}, PRKWNK1 {ECO:0000312|HGNC:HGNC:14540};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:CAC15059.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, CHROMOSOMAL
RP   LOCATION, AND VARIANTS PRO-1056; SER-1506 AND ILE-1808.
RC   TISSUE=Heart {ECO:0000312|EMBL:CAC15059.1};
RX   PubMed=11571656; DOI=10.1038/sj.onc.1204726;
RA   Verissimo F., Jordan P.;
RT   "WNK kinases, a novel protein kinase subfamily in multi-cellular
RT   organisms.";
RL   Oncogene 20:5562-5569(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Neuron;
RX   PubMed=22701532; DOI=10.1371/journal.pone.0037751;
RA   Vidal-Petiot E., Cheval L., Faugeroux J., Malard T., Doucet A.,
RA   Jeunemaitre X., Hadchouel J.;
RT   "A new methodology for quantification of alternatively spliced exons
RT   reveals a highly tissue-specific expression pattern of WNK1 isoforms.";
RL   PLoS ONE 7:E37751-E37751(2012).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PRO-1056; SER-1506 AND
RP   ILE-1808.
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-668 (ISOFORMS 1/2), FUNCTION, CATALYTIC
RP   ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=10660600; DOI=10.1074/jbc.275.6.4311;
RA   Moore T.M., Garg R., Johnson C., Coptcoat M.J., Ridley A.J., Morris J.D.H.;
RT   "PSK, a novel STE20-like kinase derived from prostatic carcinoma that
RT   activates the JNK MAPK pathway and regulates actin cytoskeletal
RT   organisation.";
RL   J. Biol. Chem. 275:4311-4322(2000).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 69-2382 (ISOFORM 2), AND VARIANTS
RP   PRO-1056 AND SER-1506.
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA20802.2};
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [7] {ECO:0000305}
RP   SEQUENCE REVISION TO N-TERMINUS.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [8]
RP   PROTEIN SEQUENCE OF 163-175, AND GLYCOSYLATION.
RX   PubMed=2507249; DOI=10.1002/9780470513828.ch7;
RA   Hart G.W., Haltiwanger R.S., Holt G.D., Kelly W.G.;
RT   "Nucleoplasmic and cytoplasmic glycoproteins.";
RL   Ciba Found. Symp. 145:102-118(1989).
RN   [9] {ECO:0000305}
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (N-TERMINUS OF ISOFORM 3), ALTERNATIVE
RP   PROMOTER USAGE, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney {ECO:0000269|PubMed:14645531};
RX   PubMed=14645531; DOI=10.1128/mcb.23.24.9208-9221.2003;
RA   Delaloy C., Lu J., Houot A.-M., Disse-Nicodeme S., Gasc J.-M., Corvol P.,
RA   Jeunemaitre X.;
RT   "Multiple promoters in the WNK1 gene: one controls expression of a kidney-
RT   specific kinase-defective isoform.";
RL   Mol. Cell. Biol. 23:9208-9221(2003).
RN   [10] {ECO:0000305}
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1/4/5).
RC   TISSUE=Placenta {ECO:0000269|PubMed:15489334};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   IDENTIFICATION (ISOFORMS 4/5), FUNCTION, AND INVOLVEMENT IN HSAN2A.
RX   PubMed=15060842; DOI=10.1086/420795;
RA   Lafreniere R.G., MacDonald M.L.E., Dube M.-P., MacFarlane J.,
RA   O'Driscoll M., Brais B., Meilleur S., Brinkman R.R., Dadivas O., Pape T.,
RA   Platon C., Radomski C., Risler J., Thompson J., Guerra-Escobio A.-M.,
RA   Davar G., Breakefield X.O., Pimstone S.N., Green R., Pryse-Phillips W.,
RA   Goldberg Y.P., Younghusband H.B., Hayden M.R., Sherrington R.,
RA   Rouleau G.A., Samuels M.E.;
RT   "Identification of a novel gene (HSN2) causing hereditary sensory and
RT   autonomic neuropathy type II through the study of Canadian genetic
RT   isolates.";
RL   Am. J. Hum. Genet. 74:1064-1073(2004).
RN   [12] {ECO:0000305}
RP   INVOLVEMENT IN PHA2C.
RX   PubMed=11498583; DOI=10.1126/science.1062844;
RA   Wilson F.H., Disse-Nicodeme S., Choate K.A., Ishikawa K.,
RA   Nelson-Williams C., Desitter I., Gunel M., Milford D.V., Lipkin G.W.,
RA   Achard J.-M., Feely M.P., Dussol B., Berland Y., Unwin R.J., Mayan H.,
RA   Simon D.B., Farfel Z., Jeunemaitre X., Lifton R.P.;
RT   "Human hypertension caused by mutations in WNK kinases.";
RL   Science 293:1107-1112(2001).
RN   [13]
RP   INVOLVEMENT IN HSAN2A.
RX   PubMed=15911806; DOI=10.1212/01.wnl.0000161849.29944.43;
RA   Roddier K., Thomas T., Marleau G., Gagnon A.M., Dicaire M.J., St Denis A.,
RA   Gosselin I., Sarrazin A.M., Larbrisseau A., Lambert M., Vanasse M.,
RA   Gaudet D., Rouleau G.A., Brais B.;
RT   "Two mutations in the HSN2 gene explain the high prevalence of HSAN2 in
RT   French Canadians.";
RL   Neurology 64:1762-1767(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2002 AND SER-2032, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1261, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   ALTERNATIVE SPLICING (ISOFORMS 4 AND 5), AND INVOLVEMENT IN HSAN2A.
RX   PubMed=18521183; DOI=10.1172/jci34088;
RA   Shekarabi M., Girard N., Riviere J.B., Dion P., Houle M., Toulouse A.,
RA   Lafreniere R.G., Vercauteren F., Hince P., Laganiere J., Rochefort D.,
RA   Faivre L., Samuels M., Rouleau G.A.;
RT   "Mutations in the nervous system--specific HSN2 exon of WNK1 cause
RT   hereditary sensory neuropathy type II.";
RL   J. Clin. Invest. 118:2496-2505(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-1261; SER-2011;
RP   SER-2012; SER-2027; SER-2029 AND SER-2032, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1978, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-1261; SER-1978;
RP   SER-2032 AND SER-2121, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2027; SER-2029 AND SER-2032,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   UBIQUITINATION BY KLHL2.
RX   PubMed=23838290; DOI=10.1016/j.bbrc.2013.06.104;
RA   Takahashi D., Mori T., Wakabayashi M., Mori Y., Susa K., Zeniya M.,
RA   Sohara E., Rai T., Sasaki S., Uchida S.;
RT   "KLHL2 interacts with and ubiquitinates WNK kinases.";
RL   Biochem. Biophys. Res. Commun. 437:457-462(2013).
RN   [25]
RP   INTERACTION WITH KLHL3.
RX   PubMed=23387299; DOI=10.1042/bj20121903;
RA   Ohta A., Schumacher F.R., Mehellou Y., Johnson C., Knebel A.,
RA   Macartney T.J., Wood N.T., Alessi D.R., Kurz T.;
RT   "The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome
RT   interacts with and ubiquitylates WNK isoforms: disease-causing mutations in
RT   KLHL3 and WNK4 disrupt interaction.";
RL   Biochem. J. 451:111-122(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-167; SER-174;
RP   SER-1261; SER-2029; SER-2032; SER-2370 AND SER-2372, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   UBIQUITINATION, AND INTERACTION WITH KLHL3.
RX   PubMed=23576762; DOI=10.1073/pnas.1304592110;
RA   Shibata S., Zhang J., Puthumana J., Stone K.L., Lifton R.P.;
RT   "Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via
RT   ubiquitination and degradation of WNK4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:7838-7843(2013).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167; SER-174; SER-1978 AND
RP   SER-2027, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [29] {ECO:0007744|PDB:4PWN}
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 210-482.
RX   PubMed=24803536; DOI=10.1126/scisignal.2005050;
RA   Piala A.T., Moon T.M., Akella R., He H., Cobb M.H., Goldsmith E.J.;
RT   "Chloride sensing by WNK1 involves inhibition of autophosphorylation.";
RL   Sci. Signal. 7:RA41-RA41(2014).
RN   [30] {ECO:0007744|PDB:5TF9}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 206-483 IN COMPLEX WITH ATP AND
RP   ALLOSTERIC INHIBITOR.
RX   PubMed=27712055; DOI=10.1021/acschembio.6b00511;
RA   Yamada K., Zhang J.H., Xie X., Reinhardt J., Xie A.Q., LaSala D., Kohls D.,
RA   Yowe D., Burdick D., Yoshisue H., Wakai H., Schmidt I., Gunawan J.,
RA   Yasoshima K., Yue Q.K., Kato M., Mogi M., Idamakanti N., Kreder N.,
RA   Drueckes P., Pandey P., Kawanami T., Huang W., Yagi Y.I., Deng Z.,
RA   Park H.M.;
RT   "Discovery and characterization of allosteric WNK kinase inhibitors.";
RL   ACS Chem. Biol. 11:3338-3346(2016).
RN   [31]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-1199 AND GLU-1799.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [32]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-141; VAL-149; GLN-419; THR-509;
RP   GLY-527; ILE-665; ALA-674; ARG-823; VAL-1546; GLU-1799; ILE-1808; LEU-1823;
RP   HIS-1957; CYS-2190; LEU-2362 AND TRP-2380.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=6;
CC         Comment=WNK1 is a complex 33-exons gene, in total 9 WNK1 exons are
CC         alternatively spliced, some expressed in a tissue-specific manner.
CC         Additional isoforms seems to exist.;
CC       Name=1 {ECO:0000269|PubMed:11571656}; Synonyms=L-WNK1;
CC         IsoId=Q9H4A3-1; Sequence=Displayed;
CC       Name=2 {ECO:0000303|PubMed:9205841};
CC         IsoId=Q9H4A3-2; Sequence=VSP_040269, VSP_050638;
CC       Name=3; Synonyms=KS-WNK1, Kidney-Specific;
CC         IsoId=Q9H4A3-4; Sequence=VSP_050634, VSP_050637;
CC       Name=4; Synonyms=Brain and spinal cord variant;
CC         IsoId=Q9H4A3-5; Sequence=VSP_040268;
CC       Name=5; Synonyms=Dorsal root ganglia and sciatic nerve variant, DRG and
CC       sciatic nerve variant;
CC         IsoId=Q9H4A3-6; Sequence=VSP_040267, VSP_040270;
CC       Name=6;
CC         IsoId=Q9H4A3-7; Sequence=VSP_040267, VSP_053767;
CC   -!- MISCELLANEOUS: Contains the nervous system-specific exon HSN2. Produced
CC       by alternative splicing. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS73419.1; -.
DR   RefSeq; NP_998820.3; NM_213655.4.
DR   ProteomicsDB; 80807; -.
DR   Ensembl; ENST00000340908.9; ENSP00000341292.5; ENSG00000060237.19.
DR   Proteomes; UP000005640; Chromosome 12.
PE   1: Evidence at protein level;
SQ   SEQUENCE   2634 AA;  279538 MW;  2F95DCDA28619B4C CRC64;
     MSGGAAEKQS STPGSLFLSP PAPAPKNGSS SDSSVGEKLG AAAADAVTGR TEEYRRRRHT
     MDKDSRGAAA TTTTTEHRFF RRSVICDSNA TALELPGLPL SLPQPSIPAA VPQSAPPEPH
     REETVTATAT SQVAQQPPAA AAPGEQAVAG PAPSTVPSST SKDRPVSQPS LVGSKEEPPP
     ARSGSGGGSA KEPQEERSQQ QDDIEELETK AVGMSNDGRF LKFDIEIGRG SFKTVYKGLD
     TETTVEVAWC ELQDRKLTKS ERQRFKEEAE MLKGLQHPNI VRFYDSWEST VKGKKCIVLV
     TELMTSGTLK TYLKRFKVMK IKVLRSWCRQ ILKGLQFLHT RTPPIIHRDL KCDNIFITGP
     TGSVKIGDLG LATLKRASFA KSVIGTPEFM APEMYEEKYD ESVDVYAFGM CMLEMATSEY
     PYSECQNAAQ IYRRVTSGVK PASFDKVAIP EVKEIIEGCI RQNKDERYSI KDLLNHAFFQ
     EETGVRVELA EEDDGEKIAI KLWLRIEDIK KLKGKYKDNE AIEFSFDLER DVPEDVAQEM
     VESGYVCEGD HKTMAKAIKD RVSLIKRKRE QRQLVREEQE KKKQEESSLK QQVEQSSASQ
     TGIKQLPSAS TGIPTASTTS ASVSTQVEPE EPEADQHQQL QYQQPSISVL SDGTVDSGQG
     SSVFTESRVS SQQTVSYGSQ HEQAHSTGTV PGHIPSTVQA QSQPHGVYPP SSVPRRGRSM
     SVCVPIFLLL PLCPASLPVL FHPTASTVCT SFSFPPPDCP EETFAEKLSK ALESVLPMHS
     ASQRKHRRSS LPSLFVSTPQ SMAHPCGGTP TYPESQIFFP TIHERPVSFS PPPTCPPKVA
     ISQRRKSTSF LEAQTHHFQP LLRTVGQSLL PPGGSPTNWT PEAVVMLGTT ASRVTGESCE
     IQVHPMFEPS QVYSDYRPGL VLPEEAHYFI PQEAVYVAGV HYQARVAEQY EGIPYNSSVL
     SSPMKQIPEQ KPVQGGPTSS SVFEFPSGQA FLVGHLQNLR LDSGLGPGSP LSSISAPIST
     DATRLKFHPV FVPHSAPAVL THNNESRSNC VFEFHVHTPS SSSGEGGGIL PQRVYRNRQV
     AVDLNQEELP PQSVGLHGYL QPVTEEKHNY HAPELTVSVV EPIGQNWPIG SPEYSSDSSQ
     ITSSDPSDFQ SPPPTGGAAA PFGSDVSMPF IHLPQTVLQE SPLFFCFPQG TTSQQVLTAS
     FSSGGSALHP QAQGQSQGQP SSSSLTGVSS SQPIQHPQQQ QGIQQTAPPQ QTVQYSLSQT
     STSSEATTAQ PVSQPQAPQV LPQVSAGKQS TQGVSQVAPA EPVAVAQTQA TQPTTLASSV
     DSAHSDVASG MSDGNENVPS SSGRHEGRTT KRHYRKSVRS RSRHEKTSRP KLRILNVSNK
     GDRVVECQLE THNRKMVTFK FDLDGDNPEE IATIMVNNDF ILAIERESFV DQVREIIEKA
     DEMLSEDVSV EPEGDQGLES LQGKDDYGFS GSQKLEGEFK QPIPASSMPQ QIGIPTSSLT
     QVVHSAGRRF IVSPVPESRL RESKVFPSEI TDTVAASTAQ SPGMNLSHSA SSLSLQQAFS
     ELRRAQMTEG PNTAPPNFSH TGPTFPVVPP FLSSIAGVPT TAAATAPVPA TSSPPNDIST
     SVIQSEVTVP TEEGIAGVAT STGVVTSGGL PIPPVSESPV LSSVVSSITI PAVVSISTTS
     PSLQVPTSTS EIVVSSTALY PSVTVSATSA SAGGSTATPG PKPPAVVSQQ AAGSTTVGAT
     LTSVSTTTSF PSTASQLCIQ LSSSTSTPTL AETVVVSAHS LDKTSHSSTT GLAFSLSAPS
     SSSSPGAGVS SYISQPGGLH PLVIPSVIAS TPILPQAAGP TSTPLLPQVP SIPPLVQPVA
     NVPAVQQTLI HSQPQPALLP NQPHTHCPEV DSDTQPKAPG IDDIKTLEEK LRSLFSEHSS
     SGAQHASVSL ETSLVIESTV TPGIPTTAVA PSKLLTSTTS TCLPPTNLPL GTVALPVTPV
     VTPGQVSTPV STTTSGVKPG TAPSKPPLTK APVLPVGTEL PAGTLPSEQL PPFPGPSLTQ
     SQQPLEDLDA QLRRTLSPEM ITVTSAVGPV SMAAPTAITE AGTQPQKGVS QVKEGPVLAT
     SSGAGVFKMG RFQVSVAADG AQKEGKNKSE DAKSVHFESS TSESSVLSSS SPESTLVKPE
     PNGITIPGIS SDVPESAHKT TASEAKSDTG QPTKVGRFQV TTTANKVGRF SVSKTEDKIT
     DTKKEGPVAS PPFMDLEQAV LPAVIPKKEK PELSEPSHLN GPSSDPEAAF LSRDVDDGSG
     SPHSPHQLSS KSLPSQNLSQ SLSNSFNSSY MSSDNESDIE DEDLKLELRR LRDKHLKEIQ
     DLQSRQKHEI ESLYTKLGKV PPAVIIPPAA PLSGRRRRPT KSKGSKSSRS SSLGNKSPQL
     SGNLSGQSAA SVLHPQQTLH PPGNIPESGQ NQLLQPLKPS PSSDNLYSAF TSDGAISVPS
     LSAPGQGTSS TNTVGATVNS QAAQAQPPAM TSSRKGTFTD DLHKLVDNWA RDAMNLSGRR
     GSKGHMNYEG PGMARKFSAP GQLCISMTSN LGGSAPISAA SATSLGHFTK SMCPPQQYGF
     PATPFGAQWS GTGGPAPQPL GQFQPVGTAS LQNFNISNLQ KSISNPPGSN LRTT
//
